Hematological immune-related adverse events associated with checkpoint inhibitors
Cancer Treatment Reviews · 2026
DOI: 10.1016/j.ctrv.2026.103121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026. Verfasst von Mélanie Janson und 3 weiteren Autor:innen. Beteiligte Einrichtung: François Baclesse, Comprehensive Cancer Center, 14 076 Caen Cedex 5, France. Electronic address: m.janson@baclesse.unicancer.fr. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Purpura, Thrombocytopenic, Idiopathic, Anemia, Hemolytic, Autoimmune, Red-Cell Aplasia, Pure. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- François Baclesse, Comprehensive Cancer Center, 14 076 Caen Cedex 5, France. Electronic address: m.janson@baclesse.unicancer.fr.
- François Baclesse, Comprehensive Cancer Center, 14 076 Caen Cedex 5, France. Electronic address: f.cherifi@baclesse.unicancer.fr.
- Hematology Institute, University Hospital & University of Caen Normandy, CNRS, Normandy University, ISTCT UMR6030, GIP Cyceron, F-14000 Caen, France. Electronic address: bardet-h@chu-caen.fr.
- Hematology Institute, University Hospital & University of Caen Normandy, CNRS, Normandy University, ISTCT UMR6030, GIP Cyceron, F-14000 Caen, France. Electronic address: damaj-gl@chu-caen.fr.
Zitieren
APA
Janson, M., Cherifi, F., Bardet, H., & Damaj, G. (2026). Hematological immune-related adverse events associated with checkpoint inhibitors. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2026.103121
Vancouver
Janson M, Cherifi F, Bardet H, Damaj G. Hematological immune-related adverse events associated with checkpoint inhibitors. Cancer Treatment Reviews. 2026. doi:10.1016/j.ctrv.2026.103121
BibTeX
@article{Janson2026,
author = {Janson, Mélanie and Cherifi, François and Bardet, Hippolyte and Damaj, Gandhi},
title = {Hematological immune-related adverse events associated with checkpoint inhibitors},
journal = {Cancer Treatment Reviews},
year = {2026},
doi = {10.1016/j.ctrv.2026.103121}
}
EUVIMED